Effect of aromatase inhibitor with LH-RH agonisit for tamoxifen resistant recurrent breast cancer
Phase 1
- Conditions
- Recurrent breast cancer
- Registration Number
- JPRN-UMIN000004365
- Lead Sponsor
- The University of Tokushima graduate school
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
male breast cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Benefit
- Secondary Outcome Measures
Name Time Method time to progression and safety